Transplant Living: Organ Donation and Transplantation Information for Patients


Medications Post-Transplant Medications Types of Immunosuppressants Switching Immunosuppressants Side Effects Other Medications Generic and Brand Name Drugs Helpful Hints Questions to Ask Pregnancy Precautions Fertility Labor and Delivery Breastfeeding Risks National Registry Staying Healthy Post-Transplant Tests Preventing Rejection Infections & Immunity Health Concerns Diet and Exercise Contacting Your Donor Family Cancer Types Risk factors Prevention and early detection Post-transplant cancer mortality		Post-transplant Cancer Mortality OPTN/UNOS data on deaths occurring between 5 and 10 years post-transplantation indicate that malignant cancer was the cause in 14.5% of kidney recipients, 21.5% of heart recipients and 18.7% of liver recipients. Reference and Publication Information The United Network for Organ Sharing is committed to providing accurate and reliable information for transplant patients. To learn more about our content authorship and review process, please read about our Editorial Board. The content on this page was originally created on May 5, 2006 by the United Network for Organ Sharing and last modified on June 30, 2006. The following sources were used as references: Kauffman, H. Myron, Cherikh, Wida S., McBride, Maureen A., Cheng, Yulin, Hanto, Douglas W. Post-Transplant De Novo Malignancies in Renal Transplant Recipients: The Past and Present. Transplantation International 2006. Transplantation 70:1747-51, 2000. First Report of the United Network for Organ Sharing Transplant Tumor Registry: Donors with a History of Cancer. This web site is intended solely for the purpose of electronically providing the public with general health-related information and convenient access to the data resources. UNOS is not affiliated with any one product nor does UNOS assume responsibility for any error, omissions or other discrepancies.		You may also want to learn about: Health concerns Post-transplant medications Helpful hints

Post-transplant Cancer

Mortality